Xtant Medical Holdings, Inc. (NYSEAM:XTNT) acquired NanOss Production Operations of RTI Surgical, Inc. for $2.2 million on October 23, 2023. Under the terms of the purchase agreement, Xtant acquired certain assets, including equipment and inventory, used in RTI?s synthetic bone graft business, and assumed from RTI the lease for the nanOss production facility located in Greenville, NC. The purchase price for the assets was $2 million in cash plus $0.2 million of contingent payments based on future sales of next generation nanOss products.

Xtant Medical Holdings, Inc. (NYSEAM:XTNT) completed the acquisition of NanOss Production Operations of RTI Surgical, Inc. on October 23, 2023. Dennis F. Adams III, Helyn S. Goldstein, Jeffrey D. Osterman, Michael Nissan, Ryan C. Taylor, Vynessa Nemunaitis and Yehudah L. Buchweitz of Weil, Gotshal & Manges LLP acted as legal advisor to Surgalign Holdings, Inc.